BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 16397018)

  • 1. Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells.
    Gritsko T; Williams A; Turkson J; Kaneko S; Bowman T; Huang M; Nam S; Eweis I; Diaz N; Sullivan D; Yoder S; Enkemann S; Eschrich S; Lee JH; Beam CA; Cheng J; Minton S; Muro-Cacho CA; Jove R
    Clin Cancer Res; 2006 Jan; 12(1):11-9. PubMed ID: 16397018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of stat3 in primary tumors from high-risk breast cancer patients is associated with elevated levels of activated SRC and survivin expression.
    Diaz N; Minton S; Cox C; Bowman T; Gritsko T; Garcia R; Eweis I; Wloch M; Livingston S; Seijo E; Cantor A; Lee JH; Beam CA; Sullivan D; Jove R; Muro-Cacho CA
    Clin Cancer Res; 2006 Jan; 12(1):20-8. PubMed ID: 16397019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression profiling revealed survivin as a target of 3,3'-diindolylmethane-induced cell growth inhibition and apoptosis in breast cancer cells.
    Rahman KW; Li Y; Wang Z; Sarkar SH; Sarkar FH
    Cancer Res; 2006 May; 66(9):4952-60. PubMed ID: 16651453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of potential Stat3-regulated genes in human breast cancer.
    Hsieh FC; Cheng G; Lin J
    Biochem Biophys Res Commun; 2005 Sep; 335(2):292-9. PubMed ID: 16081048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclooxygenase-2-dependent activation of signal transducer and activator of transcription 3 by interleukin-6 in non-small cell lung cancer.
    Dalwadi H; Krysan K; Heuze-Vourc'h N; Dohadwala M; Elashoff D; Sharma S; Cacalano N; Lichtenstein A; Dubinett S
    Clin Cancer Res; 2005 Nov; 11(21):7674-82. PubMed ID: 16278387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STAT3 is constitutively activated and supports cell survival in association with survivin expression in gastric cancer cells.
    Kanda N; Seno H; Konda Y; Marusawa H; Kanai M; Nakajima T; Kawashima T; Nanakin A; Sawabu T; Uenoyama Y; Sekikawa A; Kawada M; Suzuki K; Kayahara T; Fukui H; Sawada M; Chiba T
    Oncogene; 2004 Jun; 23(28):4921-9. PubMed ID: 15077160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of survivin by ErbB2 signaling: therapeutic implications for ErbB2-overexpressing breast cancers.
    Xia W; Bisi J; Strum J; Liu L; Carrick K; Graham KM; Treece AL; Hardwicke MA; Dush M; Liao Q; Westlund RE; Zhao S; Bacus S; Spector NL
    Cancer Res; 2006 Feb; 66(3):1640-7. PubMed ID: 16452223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis.
    Niu G; Wright KL; Huang M; Song L; Haura E; Turkson J; Zhang S; Wang T; Sinibaldi D; Coppola D; Heller R; Ellis LM; Karras J; Bromberg J; Pardoll D; Jove R; Yu H
    Oncogene; 2002 Mar; 21(13):2000-8. PubMed ID: 11960372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ectopic expression of interferon regulatory factor-1 promotes human breast cancer cell death and results in reduced expression of survivin.
    Pizzoferrato E; Liu Y; Gambotto A; Armstrong MJ; Stang MT; Gooding WE; Alber SM; Shand SH; Watkins SC; Storkus WJ; Yim JH
    Cancer Res; 2004 Nov; 64(22):8381-8. PubMed ID: 15548708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer.
    Ai Z; Yin L; Zhou X; Zhu Y; Zhu D; Yu Y; Feng Y
    Cancer; 2006 Aug; 107(4):746-56. PubMed ID: 16826583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constitutive activation of Stat3 in human prostate tumors and cell lines: direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells.
    Mora LB; Buettner R; Seigne J; Diaz J; Ahmad N; Garcia R; Bowman T; Falcone R; Fairclough R; Cantor A; Muro-Cacho C; Livingston S; Karras J; Pow-Sang J; Jove R
    Cancer Res; 2002 Nov; 62(22):6659-66. PubMed ID: 12438264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survivin mediates resistance to antiandrogen therapy in prostate cancer.
    Zhang M; Latham DE; Delaney MA; Chakravarti A
    Oncogene; 2005 Apr; 24(15):2474-82. PubMed ID: 15735703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined evaluation of expression of telomerase, survivin, and anti-apoptotic Bcl-2 family members in relation to loss of differentiation and apoptosis in human head and neck cancers.
    Sharma H; Sen S; Mathur M; Bahadur S; Singh N
    Head Neck; 2004 Aug; 26(8):733-40. PubMed ID: 15287041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of survivin expression by small interfering RNA induces apoptosis in human breast carcinoma cell line MCF-7.
    Li JX; Zhou KY; Liang T; Zhang YF
    Ai Zheng; 2005 Mar; 24(3):268-72. PubMed ID: 15757525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct expression of Survivin splice variants in breast carcinomas.
    Vegran F; Boidot R; Oudin C; Riedinger JM; Lizard-Nacol S
    Int J Oncol; 2005 Oct; 27(4):1151-7. PubMed ID: 16142334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone morphogenetic protein 7 protects prostate cancer cells from stress-induced apoptosis via both Smad and c-Jun NH2-terminal kinase pathways.
    Yang S; Lim M; Pham LK; Kendall SE; Reddi AH; Altieri DC; Roy-Burman P
    Cancer Res; 2006 Apr; 66(8):4285-90. PubMed ID: 16618753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of p53 gene alterations with the expression of antiapoptotic survivin splice variants in breast cancer.
    Végran F; Boidot R; Oudin C; Defrain C; Rebucci M; Lizard-Nacol S
    Oncogene; 2007 Jan; 26(2):290-7. PubMed ID: 16847456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stem-cell protein Piwil2 is widely expressed in tumors and inhibits apoptosis through activation of Stat3/Bcl-XL pathway.
    Lee JH; Schütte D; Wulf G; Füzesi L; Radzun HJ; Schweyer S; Engel W; Nayernia K
    Hum Mol Genet; 2006 Jan; 15(2):201-11. PubMed ID: 16377660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ribozyme-mediated inhibition of survivin expression increases spontaneous and drug-induced apoptosis and decreases the tumorigenic potential of human prostate cancer cells.
    Pennati M; Binda M; Colella G; Zoppe' M; Folini M; Vignati S; Valentini A; Citti L; De Cesare M; Pratesi G; Giacca M; Daidone MG; Zaffaroni N
    Oncogene; 2004 Jan; 23(2):386-94. PubMed ID: 14724567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway.
    Mirza A; McGuirk M; Hockenberry TN; Wu Q; Ashar H; Black S; Wen SF; Wang L; Kirschmeier P; Bishop WR; Nielsen LL; Pickett CB; Liu S
    Oncogene; 2002 Apr; 21(17):2613-22. PubMed ID: 11965534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.